NGEN · Nervgen Pharma Corp. · Exempt Offerings
Market Cap
$175.26M
Shares
107.52M
Volume · Nov 12
2.64M
Avg daily vol (3M)
543.25K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2021-12-14 | New | Other | $1,052,930 | $651,815 | 06b |
| 2021-08-25 | Amendment | Other | $5,357,419 | $2,194,379 | 06b |
| 2021-08-17 | New | Other | $442,322 | $263,692 | 06b |
| 2021-06-02 | Amendment | Other | $650,123 | $285,141 | 06b |
| 2020-08-25 | New | Other | $5,357,419 | $2,194,379 | 06b |
| 2020-06-03 | New | Other | $650,123 | $285,141 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1751912
CUSIP
64082X203
13F (30d)
36 filings
36 filers
Visit website
Investor relations